Work

Figure S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Year: 2025

Type: other

Abstract: The establishment of gefitinib-resistant cell lines, genomic alterations information of resistant patients, and the effect of MYLK-AS1 on the drug resistance of sensitive cells.

DOI: 10.1158/0008-5472.29919069

Authors: Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4413446140

Cites:

Cited by:

Related to: 10